IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q1 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $34,084,000 | +26.0% | 1,752,374 | +7.9% | 0.01% | +50.0% |
| Q4 2017 | $27,048,000 | -33.2% | 1,624,494 | -18.5% | 0.01% | -40.0% |
| Q3 2017 | $40,487,000 | +245.8% | 1,994,428 | +174.2% | 0.01% | +233.3% |
| Q2 2017 | $11,708,000 | +285.4% | 727,257 | +202.8% | 0.00% | +200.0% |
| Q1 2017 | $3,038,000 | -33.7% | 240,139 | -30.6% | 0.00% | 0.0% |
| Q4 2016 | $4,582,000 | -3.5% | 345,777 | +72.6% | 0.00% | 0.0% |
| Q3 2016 | $4,747,000 | -55.6% | 200,277 | -46.1% | 0.00% | -66.7% |
| Q2 2016 | $10,701,000 | +57.8% | 371,310 | +75.3% | 0.00% | +50.0% |
| Q1 2016 | $6,782,000 | -24.0% | 211,817 | +1.5% | 0.00% | -33.3% |
| Q4 2015 | $8,927,000 | +36.5% | 208,787 | +12.4% | 0.00% | +50.0% |
| Q3 2015 | $6,539,000 | -71.0% | 185,730 | -62.2% | 0.00% | -71.4% |
| Q2 2015 | $22,534,000 | -15.6% | 490,738 | -13.8% | 0.01% | -12.5% |
| Q1 2015 | $26,694,000 | +157.6% | 569,544 | +74.1% | 0.01% | +166.7% |
| Q4 2014 | $10,362,000 | -14.5% | 327,085 | -36.0% | 0.00% | -25.0% |
| Q3 2014 | $12,125,000 | +45.4% | 511,393 | +84.0% | 0.00% | +33.3% |
| Q2 2014 | $8,337,000 | +28.3% | 277,986 | +13.0% | 0.00% | +50.0% |
| Q1 2014 | $6,499,000 | -10.8% | 245,948 | -15.1% | 0.00% | +100.0% |
| Q4 2013 | $7,286,000 | +1162.7% | 289,852 | +929.2% | 0.00% | – |
| Q3 2013 | $577,000 | -92.1% | 28,164 | -92.3% | 0.00% | -100.0% |
| Q2 2013 | $7,287,000 | +23.9% | 365,468 | +27.4% | 0.00% | 0.0% |
| Q4 2012 | $5,879,000 | -61.7% | 286,935 | -51.4% | 0.00% | -66.7% |
| Q3 2012 | $15,339,000 | +36.9% | 590,885 | +6.9% | 0.01% | +20.0% |
| Q2 2012 | $11,204,000 | +602.9% | 552,735 | +752.5% | 0.01% | +400.0% |
| Q1 2012 | $1,594,000 | – | 64,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |